24.10
-0.02
(-0.08%)
As of 8:10:57 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 14 | 14 |
| Avg. Estimate | 208.63M | 217.13M | 882.92M | 1.01B |
| Low Estimate | 207.78M | 215.3M | 873.6M | 975.97M |
| High Estimate | 210.6M | 219.4M | 890M | 1.04B |
| Year Ago Sales | 184.73M | 192.48M | 780.62M | 882.92M |
| Sales Growth (year/est) | 12.94% | 12.81% | 13.11% | 13.97% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0SU.F | -- | -- | -- | -- |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Maintains | Stifel: Hold to Hold | 4/7/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 4/7/2025 |
| Reiterates | Needham: Hold to Hold | 4/7/2025 |
| Maintains | UBS: Neutral to Neutral | 2/26/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 2/26/2025 |
| Maintains | JP Morgan: Neutral to Neutral | 2/26/2025 |